MM
MedMira Inc.
MMIRF · OTC
$0.04 +156.25% (+$0.03)
1M +6.67%
Market Cap $39.1M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.06
46.3% upside
Trenutna cena
$0.041
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MMIRF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/S 105.47x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 36.79%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 64.42%
Net margin 730.36%
Op. margin 524.93%
Quality
59 /100
Average ROIC 27.44%
ROA 79.60%
Asset turnover 0.11x
Debt
0 /100
High Current ratio 0.06x
Int. coverage -2.08x
Debt/Equity N/A
Stability
63 /100
Moderate Beta 0.76x
Rev. volatility 25.94%
EPS volatility 21.79%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MMIRF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hermes Chan
Employees
52
Headquarters
Halifax